about
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virusStructural basis of potent Zika–dengue virus antibody cross-neutralizationYellow fever 17D as a vaccine vector for microbial CTL epitopesLive attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopesFunctional and evolutionary insight from the crystal structure of rubella virus protein E1Recognition determinants of broadly neutralizing human antibodies against dengue virusesCovalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitopeImmunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoeliiInhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses.Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralization.Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.
P50
Q24737245-E2BB9C91-2B54-454F-B0A7-0D8AB69F9155Q24740325-E992DC8A-4476-4795-A342-99F399270DB6Q27485204-044DC8F0-019A-49C2-9690-FBC7E313A818Q27485213-941F2987-3570-409C-9814-4A618BC3226FQ27683712-7077AD13-07C0-4387-9864-4690A0A5D076Q27697333-B499A034-934F-47D8-9612-2A4800BE0D35Q30250932-613CED23-2969-4B52-B37E-341190DD2C86Q34109763-ED823F9F-CAA4-463D-8F4F-D24252CF8CAAQ37347305-E2291765-62FB-41FE-AC5C-2A7D59F12945Q40053111-E4FD33AB-7366-4D18-8B29-900210E3458BQ40211546-18CF39C6-0A40-4BF1-A93B-9D4FB3886838Q45367393-AD5BAFED-4C84-432D-9FD1-5AFF855BC0DC
P50
name
Giovanna Barba-Spaeth
@en
Giovanna Barba-Spaeth
@nl
type
label
Giovanna Barba-Spaeth
@en
Giovanna Barba-Spaeth
@nl
prefLabel
Giovanna Barba-Spaeth
@en
Giovanna Barba-Spaeth
@nl